NCT06587867
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Efgartigimod, +12 more
- Locations
-
- University Health Network, Division of Neurology, Toronto General Hospital Toronto, Ontario, Canada
Clinical trial condition
Myasthenia Gravis
Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.
259 public trials
95 recruiting studies
Myasthenia Gravis trial results
NCT05214612
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Hemic and Lymphatic Diseases, +24 more
- Locations
-
- Assiut University Asyut, Egypt
Recruiting
Myasthenia Gravis Registry in China
NCT06241521
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- Beijing Hospital Beijing, Beijing Municipality, China
- Xuanwu hospital, Capital medical university Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
NCT06006832
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Recruiting
Study of Myasthenic Crisis in China
NCT04837625
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Huashan Hospital Fudan University Shanghai, Shanghai Municipality, China
Enrolling by Invitation
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
NCT06435312
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0015 40144 Milan, Italy
- Mg0015 40774 Katowice, Poland
- Mg0015 40218 Warsaw, Poland
- Mg0015 20220 Seoul, South Korea
Enrolling by Invitation
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
NCT06540144
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Mg0008 40290 Bologna, Italy
- Mg0008 40144 Milan, Italy
- Mg0008 40733 Naples, Italy
- Mg0008 20340 Fuchu-shi, Japan
Enrolling by Invitation
Serum Auto-Antibodies in Neurological Diseases
NCT00704626
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
Enrolling by Invitation
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
NCT05374590
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
- Locations
-
- Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital Chicago, Illinois, United States
- Atrium Health Neurology Specialty Care Charlotte, North Carolina, United States
- University of Virginia (UVA) Health - Developmental Pediatrics Clinic Charlottesville, Virginia, United States
- Universitair Ziekenhuis Antwerpen Edegem, Belgium
Enrolling by Invitation
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
NCT07217509
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- CorEvitas, LLC Waltham, Massachusetts, United States